Nantkwest Inc. (NASDAQ:NK) announced a $1 Million Challenge award from the …

Nantkwest Inc. (NASDAQ:NK) announced a $1 Million Challenge award from the …

“If successful, this study will lead to a novel and powerful immunotherapeutic approach to treat advanced prostate cancer.” Dr. Patrick Soon-Shiong, Founder of NantWorks and the Chairman and CEO of NantKwest, commented, “Natural killer cells have an …

(Visited 1 times, 1 visits today)
3
Like
Save

Comments

Comments are disabled for this post.